SKYE
Skye Bioscience, Inc.
NASDAQHealthcareBiotechnologyUS
Rating:C+
Company Profile
CEO
Punit Dhillon
IPO Date
2015-01-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Skye Bioscience, Inc.
CEO
Punit Dhillon
IPO Date
2015-01-06
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| $0.61 |
| 2 Apr 2026 | Twitty Christopher | Chief Scientific Officer | A-Award | Acquired | 17,004 | $0.61 |
| 2 Apr 2026 | Twitty Christopher | Chief Scientific Officer | D-Return | Disposed | 7,100 | $3.50 |
| 2 Apr 2026 | Twitty Christopher | Chief Scientific Officer | A-Award | Acquired | 75,000 | $0.61 |
| 2 Apr 2026 | Twitty Christopher | Chief Scientific Officer | D-Return | Disposed | 75,000 | $14.56 |
| 2 Apr 2026 | Twitty Christopher | Chief Scientific Officer | A-Award | Acquired | 7,100 | $0.61 |
| 2 Apr 2026 | Twitty Christopher | Chief Scientific Officer | A-Award | Acquired | 200,000 | $0.61 |
| 2 Apr 2026 | Twitty Christopher | Chief Scientific Officer | D-Return | Disposed | 200,000 | $5.15 |
| 2 Apr 2026 | Twitty Christopher | Chief Scientific Officer | A-Award | Acquired | 150,000 | $0.61 |